| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |